Medication | Addiction Professional Magazine Skip to content Skip to navigation

Medication

Vermont groups choose unusual venue for messaging on opioid crisis

October 17, 2017  |  Gary A. Enos, Editor
blog
A stigma-busting campaign focusing on opioid addiction is being launched out of the terminal in the Burlington, Vt., airport.

Troncale urges rejection of extreme positions on role of medication treatment

October 3, 2017  |  Gary A. Enos, Editor
article
In his "If I were king" talk at the Moments of Change conference, the medical director at Retreat Premier Addiction Treatment Centers advocated a balanced and comprehensive approach to combating the opioid crisis.

Review examines effect of needle exchange, opioid treatments on hepatitis C transmission

September 27, 2017  |  Gary A. Enos, Editor
news
The conclusions of a research review on hepatitis C transmission are complicated by the presence of relatively poor-quality studies, researchers report.

FDA issues guidance on MAT drugs

September 25, 2017  |  Tom Valentino, Senior Editor
article
The FDA is alerting providers and patients of the dangers of combining MAT drugs with benzodiazepines, a move that follows a recent change in labeling requirements for buprenorphine to indicate patients may require indefinite treatment.

Pharma ready to share if it helps beat the opioid crisis

September 18, 2017  |  Julie Miller, Editor in Chief
article
A public-private partnership will advance new choices for medication assisted treatment for those with opioid use disorders as well as non-addictive drugs for pain.

Drug similar to naltrexone shows promise in early research

September 18, 2017  |  Gary A. Enos, Editor
article
Research on mice leads to speculation that a drug similar to naltrexone could eventually help to prevent alcohol dependence in young drinkers.

Report suggests aggressive health initiative to improve New Jersey reentry outcomes

September 11, 2017  |  Gary A. Enos, Editor
article
Intensive case management with elements of trauma-informed care and harm reduction would improve substance use outcomes for New Jersey inmates reintegrating into the community, a new report suggests.

Opioid treatment programs growing, and expanding into other medications

August 23, 2017  |  Gary A. Enos, Editor
news
Today's opioid treatment programs (OTPs) are increasingly likely to be offering buprenorphine and injectable naltrexone treatment in addition to methadone.

NCAD: Doctor attacks misconceptions about opioid addiction medications

August 20, 2017  |  Gary A. Enos, Editor
article
The owner of Addiction Recovery Resources in Louisiana discussed why it makes sense to integrate 12-Step and medication approaches to opioid addiction treatment.

Stigma apparent in physician replies to survey on buprenorphine prescribing

August 8, 2017  |  Gary A. Enos, Editor
article
A 2016 physician survey on the prescribing of buprenorphine does indicate that counselors and other specialty providers could help physicians overcome reluctance to prescribe the opioid dependence treatment.

Massachusetts case complicates decision-making on workplace marijuana testing

August 1, 2017  |  Gary A. Enos, Editor
article
The business community nationally is closely watching a Massachusetts case in which the state's highest court has affirmed an employee's right to use marijuana for medical purposes.

Three keys to lowering mortality rates in opioid disorder patients

July 21, 2017  |  Alison Knopf, Contributing Writer
article
New research has found that providing psychosocial counseling and avoiding prescribed opioids or benzodiazepines are among the variables that can reduce mortality rates in opioid use disorders. Medication treatment did not affect death rates.

Pages

Subscribe to Medication